Galavit sublingual pills 25mg, 20pcs

Composition

of 1 tab. contains:

Active ingredients:

aminodihydrophthalazinedione sodium-25 mg

Auxiliary substances:

sorbitol – 0.315 g,

starch-0.14 g,

lactose-0.1 g,

calcium stearate-0.005 g,

talc-0.015 g,

Racementhol (menthol) – 0.0001 g.

Pharmacological action

An immunomodulatory and anti-inflammatory agent.

CodATH: L03

Pharmacological properties:

Pharmacodynamics

The mechanism of action of the drug is related to its ability to regulate the functional and metabolic activity of innate and adaptive immune cells (monocytes, macrophages, neutrophils, natural killers, etc. ).

Galavit normalizes phagocytic activity of monocytes/macrophages, bactericidal activity of neutrophils and cytotoxic activity of NK cells. At the same time, restoring the reduced activity of cells of innate and adaptive immunity, the drug increases the body’s resistance to infectious diseases of bacterial, viral and fungal etiology, promotes faster elimination of the pathogen from the body, reduces the frequency, severity and duration of infections.

In addition, Galavit normalizes antibody formation, increases functional activity (affinity) It indirectly regulates the production of endogenous interferons (IFN-a, IFN-y) by producing cells. In inflammatory diseases, the drug reversibly inhibits excessive synthesis of tumor necrosis factor-a, interleukin-1, interleukin-6 and other pro-inflammatory cytokines by hyperactivated macrophages for 6-8 hours, the level of which determines the degree of inflammatory reactions, their cyclicity, and the severity of intoxication of the body.

Galavit reduces the production of reactive oxygen species by hyperactivated macrophages, thereby reducing the level of oxidative stress and protecting tissues and organs from the damaging effects of radicals. Normalization of excessively increased functional activity of phagocytic cells leads to the restoration of their antigen-presenting and regulating functions, and a decrease in the level of autoaggression.

The drug is well tolerated and has no allergenic, mutagenic, embryotoxic, teratogenic or carcinogenic effects.

Pharmacokinetics

It is excreted from the body mainly through the kidneys. For sublingual use, the elimination half-life is 30 minutes. The main pharmacological effects are observed within 72 hours.

Indications

In adults and adolescents over 12 years of age (including those with secondary immune insufficiency) as an immunomodulatory and anti-inflammatory agent in complex therapy:

• acute respiratory infections, diseases of the respiratory tract and ENT organs (including the often recurrent) bacterial and viral etiology (SARS, influenza, bronchitis, pneumonia, tonsillitis, otitis media, adenoiditis) and their prevention;
• inflammatory diseases of the mucous membrane of the mouth and throat, periodontal disease;
• chronic relapsing disease caused by the herpes virus;
• decline in physical performance (including in athletes).

Use during pregnancy and lactation

The drug is contraindicated in pregnant women, women during breastfeeding.

Contraindications

Individual intolerance, galactose and fructose intolerance, lactase deficiency or glucose-galactose malabsorption, pregnancy and lactation, children under 12 years of age.

Side effects

In rare cases, allergic reactions are possible.

If you experience any of the side effects listed in the instructions or they get worse, or you notice any other side effects not listed in the instructions, tell your doctor.

Interaction

With simultaneous use, it is possible to reduce the course doses of antibiotics. Galavit increases the effectiveness of antibiotic therapy and reduces its side effects.

Incompatibilities with other medicinal products have not been reported.

How to take, course of use and dosage

Sublingual 1 tablet up to 4 times a day or 2 tablets 2 times a day:

For acute respiratory infections, flu, bronchitis, pneumonia, tonsillitis, otitis, adenoiditis for treatment: 1 tablet 4 times a day. The course is 5 days.

With chronic and frequent recurrent course, continue 1 tablet 4 times a day every other day for a course of up to 15 days.

For prevention: 1 tablet 2 times a day. The course is 5-10 days.

For inflammatory diseases of the oral and pharyngeal mucosa, periodontal diseases: 1 tablet 4 times a day for 5 days. Then 1 tablet 4 times a day after 3 days with a course of up to 3 weeks.

For chronic recurrent diseases caused by the herpes virus:  take 1 tablet 4 times a day for 10 days. Then take 1 tablet 4 times a day every other day for 10 days.

To improve physical performance:

1 tablet 4 times every other day for 10 days, then 1 tablet 4 times a day after 3 days with a course of up to 3 weeks.

Treatment with Galavit can be started at any stage of the disease.

Use the drug according to the indications, the method of use and in the doses indicated in the instructions.

If there is no improvement after these courses of treatment, or if the symptoms worsen or new symptoms appear, you should consult your doctor.

Overdose

No cases of overdose have been reported.

Description

Tablets are white with a yellowish tinge, biconvex, without risk, with a menthol smell.

Special instructions

The drug contains sorbitol, patients with rare hereditary pathologies associated with fructose and sorbitol intolerance should not take the drug.

Influence on the ability to drive vehicles and mechanisms:

The drug does not affect the ability to drive vehicles and work with mechanisms.

Form of production

Sublingual tablets,25 mg.

Storage conditions

Store at a temperature not exceeding 25°C, in a place protected from light.

Keep out of reach of children.

Shelf

life is 3 years.

Do not use after the expiration date indicated on the carton.

Active ingredient

Sodium aminodihydrophthalazinedione

Dosage form

Tablets

Description

Children over 12 years old, For adults

Indications

Alcoholism, Herpes, Bronchitis, Stomach and Duodenal Ulcers, Periodontitis, Colds, Oral Inflammation, Boils, Urinary Tract Infections, Tonsillitis, Otitis Media, Hepatitis, Diarrhea